Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimising inhaled beta2 agonist dose as reliever medicine for wheezy preschool children
2014-001978-33Phase 4Completed
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of salbutamol in recurrent wheeze, wheeze and airway morbidity, sponsored by Brighton and Sussex University Hospitals NHS Trust. Primary endpoint: Bronchodilator response to salbutamol. Started May 2014; status: completed.
02
Drugs
salbutamol
03
Conditions
recurrent wheezewheezeairway morbidity
Beyond the preview
Go deeper on 2014-001978-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001978-33.